Lobbyists Employed

  • Johnson, Deron A
    (Details)

    305 Stable View Ct
    Parkton, MD 21120

    (410) 357-5776

    Registered: 5/4/2012
    Matters: Issues pertaining to the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors
    Job title: Senior Manager, State Government Affairs

  • Snider, Kipp
    (Details)

    601 13th St NW
    Fl 12
    Washington, DC 20005

    (202) 585-9640

    Registered: 2/21/2013
    Matters: Issues pertaining to the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors
    Job title: Director, State Government Affairs

Lobbyists Retained

  • Bear, Catherine
    Firm: State & Federal Communications
    (Details)

    3800 Powell Ln
    APT 207
    Falls Church, VA 22041

    (703) 379-1335

    Registered: 2/5/2013
    Firm: State & Federal Communications
    Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability

  • Cox, Tyler Siegel
    Firm: Hancock Daniel & Johnson PC
    (Details)

    4701 Cox Rd
    STE 400
    Glen Allen, VA 23060

    (804) 967-9604

    Registered: 8/16/2012
    Firm: Hancock Daniel & Johnson PC
    Matters: All matters pertaining to pharmaceuticals.

  • Duvall, Charles R Jr
    Firm: Lindl Corp
    (Details)

    PO Box 170
    Richmond, VA 23218

    (804) 644-7884

    Registered: 1/21/2013
    Firm: Lindl Corp
    Matters: All matters pertaining to pharmaceuticals.

  • Johnson, W Scott
    Firm: Hancock Daniel & Johnson PC
    (Details)

    4701 Cox Rd
    Ste 400
    Glen Allen, VA 23060

    (804) 967-9604

    Registered: 5/7/2012
    Firm: Hancock Daniel & Johnson PC
    Matters: All matters pertaining to pharmaceuticals.

  • Lawrence, Timothy
    Firm: State & Federal Communications
    (Details)

    1101 K St NW
    Suite 310
    Washington, DC 20005

    (202) 365-7457

    Registered: 1/16/2013
    Firm: State & Federal Communications
    Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability

  • Metheny, Wesley
    Firm: State & Federal Communications
    (Details)

    1101 K Street NW
    Suite 310
    Washington, DC 20005

    (202) 731-3381

    Registered: 1/16/2013
    Firm: State & Federal Communications
    Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability

  • Seibert, Aimee Perron
    Firm: Hillbridge Group
    (Details)

    28 N 8th St
    Fl 1
    Richmond, VA 23219

    (804) 647-3140

    Registered: 2/1/2013
    Firm: Hillbridge Group
    Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability.

  • Whitehead, D Calloway III
    Firm: Whitehead Consulting
    (Details)

    28 N 8th St
    Fl 2
    Richmond, VA 23219

    (804) 389-2825

    Registered: 1/22/2013
    Firm: Whitehead Consulting
    Matters: Issues pertaining to patient protections with respect to biosimilar interchangeablitity and the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors

Matters: Issues pertaining to patient protections with respect to biosimilar interchangeablitity and the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors

Principal contact for Amgen Inc:

  • Kathy Feegel
    601 13th St NW
    Fl 12
    Washington, DC 20005

    (202) 585-9614

Information on this page comes from public documents on file with the office of the Virginia Conflict of Interest and Ethics Advisory Council.